Search

everythinglearnresearchcommunity

for

Search:↓

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Hair thickness differences help diagnose hair loss severity.

Most hair loss in children is caused by a few common conditions, and it's important to diagnose these properly and support the child's mental health.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

WNT10A mutations cause varied symptoms in patients with odonto-onycho-dermal dysplasia.

A gene deletion causes the "hairless" trait in Iffa Credo rats.

Platelet-Rich Plasma (PRP) shows promise for hair growth and skin improvement in aesthetic surgery.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Consider benefits and risks of new alopecia treatments for safety.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Pulsed-intense light can significantly reduce hair, with effectiveness depending on treatment number and timing, and has mild side effects.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Stem cells can rejuvenate skin, restore hair, and aid in wound healing.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Looking at skin can help find and treat serious diseases early.

The document suggests that certain protein deficiencies and scalp blistering in Epidermolysis Bullosa may cause hair loss.

Platelet-based therapies using a patient's own blood show promise for skin and hair regeneration but require more research for confirmation.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.